Cheever; Martin A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cheever; Martin A..The latest application filed is for "compositions and methods for wt1 specific immunotherapy".

Company Profile

0.26.26

Cheever; Martin A. - Mercer Island WA US
Cheever; Martin A - Mercer Island WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
HER-2/neu fusion proteins Grant 8,568,733 - Cheever , et al. October 29, 2	2013-10-29
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated Grant 8,524,491 - Cheever , et al. September 3, 2	2013-09-03
Compositions And Methods For Wt1 Specific Immunotherapy App 20120301492 - Gaiger; Alexander ; et al.	2012-11-29
Compositions and methods for WT1 specific immunotherapy Grant 7,901,693 - Gaiger , et al. March 8, 2	2011-03-08
Compositions And Methods For Wt1 Specific Immunotherapy App 20100166738 - Gaiger; Alexander ; et al.	2010-07-01
Immune Reactivity To Her-2/neu Protein For Diagnosis And Treatment Of Malignancies In Which The Her-2/neu Oncogene Is Associated App 20100087621 - Cheever; Martin A. ; et al.	2010-04-08
Compositions and methods for WT1 specific immunotherapy Grant 7,662,386 - Gaiger , et al. February 16, 2	2010-02-16
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated Grant 7,655,239 - Cheever , et al. February 2, 2	2010-02-02
COMPOUNDS FOR ELICITING OR ENHANCING IMMUNE REACTIVITY TO HER-2/neu PROTEIN FOR PREVENTION OR TREATMENT OF MALIGNANCIES IN WHICH THE HER-2/neu ONCOGENE IS ASSOCIATED App 20100010075 - CHEEVER; Martin A. ; et al.	2010-01-14
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated Grant 7,601,697 - Cheever , et al. October 13, 2	2009-10-13
Compositions And Methods For Wt1 Specific Immunotherapy App 20080241268 - Gaiger; Alexander ; et al.	2008-10-02
Her-2/neu Fusion Proteins App 20080213295 - Cheever; Martin A. ; et al.	2008-09-04
HER-2/neu fusion proteins Grant 7,375,091 - Cheever , et al. May 20, 2	2008-05-20
Compositions and methods for WT1 specific immunotherapy Grant 7,368,119 - Gaiger , et al. May 6, 2	2008-05-06
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated App 20080076904 - Cheever; Martin A. ; et al.	2008-03-27
Compositions and method for WT1 specific immunotherapy Grant 7,329,410 - Gaiger , et al. February 12, 2	2008-02-12
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated Grant 7,247,703 - Cheever , et al. July 24, 2	2007-07-24
Her-2/neu fusion proteins Grant 7,229,623 - Cheever , et al. June 12, 2	2007-06-12
HER-2/neu fusion proteins Grant 7,198,920 - Cheever , et al. April 3, 2	2007-04-03
Compositions and methods for WT1 specific immunotherapy App 20070026008 - Gaiger; Alexander ; et al.	2007-02-01
Compositions and methods for WT1 specific immunotherapy Grant 7,144,581 - Gaiger , et al. December 5, 2	2006-12-05
Compositions and methods for WT1 specific immunotherapy Grant 7,115,272 - Gaiger , et al. October 3, 2	2006-10-03
Composition and methods for WTI specific immunotherapy Grant 7,063,854 - Gaiger , et al. June 20, 2	2006-06-20
Compositions and methods for WT1 specific immunotherapy App 20060121046 - Gaiger; Alexander ; et al.	2006-06-08
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins App 20060008479 - Cheever; Martin A. ; et al.	2006-01-12
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated Grant 6,953,573 - Cheever , et al. October 11, 2	2005-10-11
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins Grant 6,942,862 - Cheever , et al. September 13, 2	2005-09-13
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated App 20050191285 - Cheever, Martin A. ; et al.	2005-09-01
Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy App 20040235070 - Cheever, Martin A. ; et al.	2004-11-25
Compositions and methods for WT1 specific immunotherapy App 20040126362 - Gaiger, Alexander ; et al.	2004-07-01
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated App 20040082758 - Cheever, Martin A. ; et al.	2004-04-29
Compositions and methods for WT1 specific immunotherapy App 20030235557 - Gaiger, Alexander ; et al.	2003-12-25
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated Grant 6,664,370 - Cheever , et al. December 16, 2	2003-12-16
Compositions and methods for WT1 specific immunotherapy App 20030198622 - Gaiger, Alexander ; et al.	2003-10-23
Methods for diagnosis and therapy of hematological and virus-associated malignancies App 20030157119 - Gaiger, Alexander ; et al.	2003-08-21
Compositions and methods for diagnosis and therapy of malignant mesothelioma App 20030082194 - Gaiger, Alexander ; et al.	2003-05-01
Compositions and methods for WT1 specific immunotherapy App 20030082196 - Gaiger, Alexander ; et al.	2003-05-01
Immune Reactivity To Expressed Activated Oncogenes For Diagnosis And Treatment Of Malignancy App 20030083229 - CHEEVER, MARTIN A. ; et al.	2003-05-01
Compositions and methods for WT1 specific immunotherapy App 20030039635 - Gaiger, Alexander ; et al.	2003-02-27
Compositions and methods for the therapy and diagnosis of Her-2/neu-associated malignancies App 20020193329 - Hand-Zimmermann, Susan ; et al.	2002-12-19
HER-2/neu fusion proteins App 20020177567 - Cheever, Martin A. ; et al.	2002-11-28
Immune Reactivity To Her-2/neu Protein For Diagnosis And Treatment Of Malignancies In Which The Her-2/neu Oncogene Is Associated App 20020055614 - CHEEVER, MARTIN A ; et al.	2002-05-09
Compounds and methods for prevention and treatment of HER-2/neu associated malignancies App 20020039573 - Cheever, Martin A. ; et al.	2002-04-04
Methods And Compositions To Generate Immunity In Humans Against Self Tumor Antigens By Immunization With Homologous Foreign Proteins App 20020019331 - CHEEVER, MARTIN A ; et al.	2002-02-14
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated Grant 5,876,712 - Cheever , et al. March 2, 1	1999-03-02
Methods for eliciting or enhancing reactivity to HER-2/neu protein Grant 5,869,445 - Cheever , et al. February 9, 1	1999-02-09
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated Grant 5,846,538 - Cheever , et al. December 8, 1	1998-12-08
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated Grant 5,801,005 - Cheever , et al. September 1, 1	1998-09-01
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated Grant 5,726,023 - Cheever , et al. March 10, 1	1998-03-10
Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy Grant 5,601,989 - Cheever , et al. February 11, 1	1997-02-11

Company Registrations

NCAGE Code	4WBL2	CHEEVER MARTIN A
CAGE Code	4WBL2	CHEEVER MARTIN A

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.